7th Annual TIL Therapies Summit

Topics

• Current Opportunities & Excitement in the TIL Field for Future Expansion
• Preclinical & Translation
• Next Generation TIL Products for Enhanced Potency
• Clinical Strategy & Manufacturing
• Sample Collection Methods to Set Manufacturing Up for Success
• Resources Between Industry & Academia to Accelerate TIL Discovery
• Strategies for Enriching Tumor Reactive T-Cells to Maximize Manufacturing TIL Count
• Improving Patient Outcomes & Toxicity of TIL Therapies by Reducing IL2 Burden
• Improving Clarity & Synchronization of Efforts for Successful Development & Commercialization of TILs
• Equipping TILs with Necessary Modifications to Persist in Immunosuppressive Tumor Microenvironments
• Approaches to Simulating Neoantigen Reactive T-Cells for an Effective & Prolonged Response
• The Wealth of TILs: Navigating the Commercial Landscape
• Adverse Events for Improved Patient Treatment & Clinical Retention
• TIL & Solid Tumor Mechanisms to Develop an Effective TIL Product